SIMABS NV is a Contract Development and Manufacturing Organisation for monoclonal antibodies. We deliver fast, flexible and cost effective total solutions for your development and manufacturing by means of a new and unique manufacturing platform based on continuous bioprocessing.
This platform allows us to produce several complex antibodies (monoclonal, bispecific antibodies for immunotherapy, multivalent, Covid-19 applications…) for small biopharmaceutical companies. This platform will enable personalised medicine to become an affordable reality.
